DXCM240816P110000
- 39.08
- -2.52-6.06%
DexCom Newsroom
We Think DexCom (NASDAQ:DXCM) Can Manage Its Debt With Ease
DexCom (DXCM) Faces Investor Scrutiny After Revealing Details About "Disruptive" Sales Force Expansion, Shares Plummet - Hagens Berman
DexCom, Inc. (DXCM) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
Over 50% of the Nasdaq-100 Names Trade Below Their 200-day Moving Average
Jim Cramer: This Energy Stock Is A Buy, Stay Away From DexCom
Dexcom (DXCM) Receives a Buy From Wells Fargo
Abbott to Integrate CGM System With Medtronic's Insulin Delivery Devices
Down 40% in 1 Day, Is DexCom Stock Still a Buy?
Express News | Dexcom Inc : Baird Raises Target Price to $82 From $80
Here's How Much You Would Have Made Owning DexCom Stock In The Last 15 Years
Baird Downgrades DexCom(DXCM.US) to Hold Rating, Cuts Target Price to $82
Express News | Baird Downgrades DexCom to Neutral, Lowers Price Target to $80
DoorDash And Exact Sciences Are Among Top 10 Large Cap Gainers Last Week (July 28-Aug 3): Are The Others In Your Portfolio?
DexCom, Abbott to Benefit From Multi-billion-dollar OTC Continuous Glucose Market
Does DexCom (DXCM) Have a Long Runway For Growth?
It's No Surprise This Stock Had an Awful July. A Huge Tech Outage Can Do That.
BTIG Reaffirms Their Buy Rating on Dexcom (DXCM)
Express News | Dexcom Outlook FY Revenue USD 4,000-4,050 Million
Jim Cramer Says This Home Improvement Chain Is A Buy Ahead Of Fed Rate Cut Cycle: 'I Would Pick Some Up Tomorrow'
Top 3 Health Care Stocks That May Explode In Q3